ArticleJournal of neuro-oncology2018

UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.

Evan F Garner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.